Compliances Certificate under Reg. 74(5).
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Transgene Biotek Limited. Press Release Mar 29 2025
- Closure of Trading Window
- Transgene Biotek Limited. Press Release Feb 14 2025
- Integrated Filing (Financial)
Later from Transgene Biotek
- Statement Of Deviation & Variation
- Transgene Biotek Limited. Press Release Apr 19 2025
- Transgene Biotek Limited. Press Release Apr 24 2025
- We Are Enclosing Hereto The Compliance Certificate As Per Clause 40(9) In The Prescribed Format For The Quarter Ended 31St March, 2025
- Compliance-57 (5): intimation after the end of quarter
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek